Literature DB >> 10592138

Occupational exposure to environmental tobacco smoke and health risk assessment.

M S Jaakkola1, J M Samet.   

Abstract

This article addresses concepts of environmental tobacco smoke (ETS) exposure assessment relevant for health risk assessment based on human studies. We present issues that should be considered when selecting a method for ETS exposure assessment for the purposes of health risk assessment and review data on ETS exposure levels in the workplace and in home environments. Two types of estimates are needed for a quantitative risk assessment of the health effects resulting from occupational ETS exposure: (italic)a(/italic)) an unbiased estimate of the exposure-effect (or dose-response) relation between ETS and the health effect of interest, and (italic)b(/italic)) estimates of the distribution of ETS exposure in different workplaces. By combining the estimated exposure-effect relation with information on exposure distribution for a population of interest, we can calculate the proportions of disease cases attributable to occupational ETS exposure as well as the excess number of cases due to specified exposure conditions. Several dimensions of the exposure profile should be considered when assessing ETS exposure for estimating the exposure-effect relation, including the magnitude of exposure and the biologically relevant time specificity of exposure. The magnitude of exposure is determined by the ETS source strength, environmental factors modifying concentrations, and duration of exposure. Time specificity considerations include the latency period for each health outcome of interest, the time-exposure profile relevant for different disease mechanisms, and the sensitive age period with regard to health effects. The most appropriate indicator of ETS exposure depends on these factors and on the time period that can be assessed with different methods.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592138      PMCID: PMC1566195          DOI: 10.1289/ehp.99107s6829

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  21 in total

Review 1.  Passive smoking and heart disease. Epidemiology, physiology, and biochemistry.

Authors:  S A Glantz; W W Parmley
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

Review 2.  Human exposure assessment: the birth of a new science.

Authors:  W R Ott
Journal:  J Expo Anal Environ Epidemiol       Date:  1995 Oct-Dec

Review 3.  Cotinine as a biomarker of environmental tobacco smoke exposure.

Authors:  N L Benowitz
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

4.  Elevated blood levels of carcinogens in passive smokers.

Authors:  M Maclure; R B Katz; M S Bryant; P L Skipper; S R Tannenbaum
Journal:  Am J Public Health       Date:  1989-10       Impact factor: 9.308

5.  Uptake of nicotine in hair during controlled environmental air exposure to nicotine vapour: evidence for a major contribution of environmental nicotine to the overall nicotine found in hair from smokers and non-smokers.

Authors:  T Nilsen; K Zahlsen; O G Nilsen
Journal:  Pharmacol Toxicol       Date:  1994 Sep-Oct

Review 6.  Exposure to environmental tobacco smoke and adult non-neoplastic respiratory diseases.

Authors:  J Trédaniel; P Boffetta; R Saracci; A Hirsch
Journal:  Eur Respir J       Date:  1994-01       Impact factor: 16.671

7.  A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke.

Authors:  S S Hecht; S G Carmella; S E Murphy; S Akerkar; K D Brunnemann; D Hoffmann
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

8.  Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.

Authors:  S K Hammond; J Coghlin; P H Gann; M Paul; K Taghizadeh; P L Skipper; S R Tannenbaum
Journal:  J Natl Cancer Inst       Date:  1993-03-17       Impact factor: 13.506

9.  Biomarkers of environmental tobacco smoke in preschool children and their mothers.

Authors:  F G Crawford; J Mayer; R M Santella; T B Cooper; R Ottman; W Y Tsai; G Simon-Cereijido; M Wang; D Tang; F P Perera
Journal:  J Natl Cancer Inst       Date:  1994-09-21       Impact factor: 13.506

Review 10.  Assessing exposures to inhaled complex mixtures.

Authors:  B P Leaderer; P J Lioy; J D Spengler
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more
  6 in total

1.  Environmental tobacco smoke and adult-onset asthma: a population-based incident case-control study.

Authors:  Maritta S Jaakkola; Ritva Piipari; Niina Jaakkola; Jouni J K Jaakkola
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

2.  Environmental tobacco smoke exposure in public places of European cities.

Authors:  M Nebot; M J López; G Gorini; M Neuberger; S Axelsson; M Pilali; C Fonseca; K Abdennbi; A Hackshaw; H Moshammer; A M Laurent; J Salles; M Georgouli; M C Fondelli; E Serrahima; F Centrich; S K Hammond
Journal:  Tob Control       Date:  2005-02       Impact factor: 7.552

Review 3.  Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights.

Authors:  Esther Barreiro; Víctor Bustamante; Víctor Curull; Joaquim Gea; José Luis López-Campos; Xavier Muñoz
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

4.  Influence of asthma on the validity of reported lifelong environmental tobacco smoke in the EGEA study.

Authors:  Valérie Siroux; Philippe Guilbert; Nicole Le Moual; Marie-Pierre Oryszczyn; Francine Kauffmann
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Acute exposure to environmental tobacco smoke and heart rate variability.

Authors:  C A Pope; D J Eatough; D R Gold; Y Pang; K R Nielsen; P Nath; R L Verrier; R E Kanner
Journal:  Environ Health Perspect       Date:  2001-07       Impact factor: 9.031

6.  Summary: workshop on health risks attributable to ETS exposure in the workplace.

Authors:  M S Jaakkola; J M Samet
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.